WorldHeart receives $10-million TPC investment

World Heart Corp has received a $10-million repayable loan from Technology Partnerships Canada (TPC) to conduct clinical trials of its first generation HeartSaver ventricular assist device (VAD). TPC has also indicated it will consider funding the next two generations of the fully implantable heart assist device. Ottawa-based World Heart has been developing the product for the past several years, targeting patients awaiting heart transplants and those less-critical individuals requiring indeterminate care. The medical device is powered and monitored wirelessly, providing pulse and enhanced blood flow….